VYNE Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.About VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology.
CEODavid Domzalski
CEODavid Domzalski
Employees13
Employees13
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2011
Founded2011
Employees13
Employees13
VYNE Key Statistics
Market cap7.77M
Market cap7.77M
Price-Earnings ratio-0.34
Price-Earnings ratio-0.34
Dividend yield—
Dividend yield—
Average volume1.63M
Average volume1.63M
High today$0.3182
High today$0.3182
Low today$0.295
Low today$0.295
Open price$0.3105
Open price$0.3105
Volume1.75M
Volume1.75M
52 Week high$4.30
52 Week high$4.30
52 Week low$0.2805
52 Week low$0.2805
People also own
Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.